These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1323 related items for PubMed ID: 17766723

  • 1. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 2. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS, Rhim H, Cho OK, Koh BH, Kim Y.
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H.
    J Gastroenterol; 2003 Sep; 38(10):977-81. PubMed ID: 14614605
    [Abstract] [Full Text] [Related]

  • 4. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 6. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL, Ye SL, Zou JH, Ren ZG, Gan YH, Wang YH, Chen Y, Ge NL, Tang ZY, Yang BH.
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [Abstract] [Full Text] [Related]

  • 7. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.
    Oncology; 2007 Sep; 72 Suppl 1():98-103. PubMed ID: 18087189
    [Abstract] [Full Text] [Related]

  • 8. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group.
    J Hepatobiliary Pancreat Surg; 2009 Sep; 16(3):359-66. PubMed ID: 19300896
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML, Lin CC, Lin CJ, Chen WT, Lin SM.
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [Abstract] [Full Text] [Related]

  • 10. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T.
    Cancer; 2003 Mar 01; 97(5):1253-62. PubMed ID: 12599233
    [Abstract] [Full Text] [Related]

  • 12. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec 01; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M.
    J Am Coll Surg; 2003 Nov 01; 197(5):759-64. PubMed ID: 14585410
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J.
    Liver Transpl; 2002 Dec 01; 8(12):1165-74. PubMed ID: 12474157
    [Abstract] [Full Text] [Related]

  • 16. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.
    J Gastroenterol Hepatol; 2009 Feb 01; 24(2):223-7. PubMed ID: 18823439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA.
    Ann Surg Oncol; 2005 Aug 01; 12(8):616-28. PubMed ID: 15965731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.